Prolonged clinical remission and low disease activity statuses are associated with better quality of life in systemic lupus erythematosus.

Prolonged CR and LDA are associated with better HRQoL in SLE patients and have a comparable effect. Prolonged CR or optional LDA may be used as the treatment goal of a treat to target approach in SLE.